LifeScience Clinical & Diagnostic
The agreement between Quest and Agilent will enable broad adoption for ctDx FIRST, a single-site premarket approved (ssPMA) test performed at the Resolutio...
January 23, 2023 | News
Following an evaluation of the full set of Phase 2 data from the recently completed clinical trial in advanced cervical cancer, Korea’s Health Author...
January 23, 2023 | News
Irish company Renew Pharmaceuticals Limited (Renew) led an A$8 million capital raise, with a further A$3 million secured via an Au...
January 23, 2023 | News
▶ Securing breast and ovarian cancer precision diagnosis reference through clinical evaluation ▶ Expansion of opportunities to develops global advance...
January 19, 2023 | News
Lunit to present two abstracts featuring Lunit SCOPE IO, the company's AI biomarker for immune phenotyping Lunit's presentations this year will highligh...
January 19, 2023 | News
Ritonavir tablet is a pharmacokinetic booster of multiple oral antiviral protease inhibitors. Ascletis currently owns the only authorized ritonavir oral ta...
January 17, 2023 | News
The GeneFix® Saliva DNA/RNA Collection devices are market leading and designed for the collection and preservation of DNA/RNA from saliva, pr...
January 11, 2023 | News
Multi-million-dollar investment sets up new facility in Phoenix, AZ, that will focus on production of custom DNA and protein biosensors and other microar...
January 10, 2023 | News
The patent provides a proprietary position for multiple development candidates in Cartherics’ pipeline. Specifically, it covers Cartherics’ chi...
January 09, 2023 | News
Innovative chemistries enable simultaneous genomic and epigenomic profiling on the same sample, yielding greater insights for precision medicine Agilent T...
January 06, 2023 | News
Addressing health burden in neuro-degenerative diseases, cardiovascular diseases, and auto-immune and inflammatory diseases that affect hundreds of milli...
January 06, 2023 | News
Expands Specialty Diagnostics Segment with Industry Leader in Oncology Testing for Detection and Monitoring of Multiple Myeloma Complements Existing...
January 03, 2023 | News
Winlevi® is a first-in-class topical drug for the treatment of acne approved by U.S. FDA in August 2020. It will reinforce our Pr...
December 26, 2022 | News
The binding agreement focuses on collaboration in four key areas including localizing innovative industries, research and development, innovation and susta...
December 21, 2022 | News
Most Read
Bio Jobs
News
Editor Picks